469 related articles for article (PubMed ID: 27532268)
1. Low Expression of DYRK2 (Dual Specificity Tyrosine Phosphorylation Regulated Kinase 2) Correlates with Poor Prognosis in Colorectal Cancer.
Yan H; Hu K; Wu W; Li Y; Tian H; Chu Z; Koeffler HP; Yin D
PLoS One; 2016; 11(8):e0159954. PubMed ID: 27532268
[TBL] [Abstract][Full Text] [Related]
2. Dual-specificity tyrosine-regulated kinase 2 is a suppressor and potential prognostic marker for liver metastasis of colorectal cancer.
Ito D; Yogosawa S; Mimoto R; Hirooka S; Horiuchi T; Eto K; Yanaga K; Yoshida K
Cancer Sci; 2017 Aug; 108(8):1565-1573. PubMed ID: 28502078
[TBL] [Abstract][Full Text] [Related]
3. Expression of dual-specificity tyrosine-(Y)-phosphorylation-regulated kinase 2 (DYRK2) can be a favorable prognostic marker in pulmonary adenocarcinoma.
Yamashita S; Chujo M; Tokuishi K; Anami K; Miyawaki M; Yamamoto S; Kawahara K
J Thorac Cardiovasc Surg; 2009 Dec; 138(6):1303-8. PubMed ID: 19818968
[TBL] [Abstract][Full Text] [Related]
4. Impairment of DYRK2 by DNMT1‑mediated transcription augments carcinogenesis in human colorectal cancer.
Kumamoto T; Yamada K; Yoshida S; Aoki K; Hirooka S; Eto K; Yanaga K; Yoshida K
Int J Oncol; 2020 Jun; 56(6):1529-1539. PubMed ID: 32236621
[TBL] [Abstract][Full Text] [Related]
5. Silencing of DYRK2 increases cell proliferation but reverses CAM-DR in Non-Hodgkin's Lymphoma.
Wang Y; Wu Y; Miao X; Zhu X; Miao X; He Y; Zhong F; Ding L; Liu J; Tang J; Huang Y; Xu X; He S
Int J Biol Macromol; 2015 Nov; 81():809-17. PubMed ID: 26341817
[TBL] [Abstract][Full Text] [Related]
6. Amplification and overexpression of the dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 2 (DYRK2) gene in esophageal and lung adenocarcinomas.
Miller CT; Aggarwal S; Lin TK; Dagenais SL; Contreras JI; Orringer MB; Glover TW; Beer DG; Lin L
Cancer Res; 2003 Jul; 63(14):4136-43. PubMed ID: 12874018
[TBL] [Abstract][Full Text] [Related]
7. Identification and characterization of ANO9 in stage II and III colorectal carcinoma.
Li C; Cai S; Wang X; Jiang Z
Oncotarget; 2015 Oct; 6(30):29324-34. PubMed ID: 26317553
[TBL] [Abstract][Full Text] [Related]
8. FOXM1 expression correlates with tumor invasion and a poor prognosis of colorectal cancer.
Chu XY; Zhu ZM; Chen LB; Wang JH; Su QS; Yang JR; Lin Y; Xue LJ; Liu XB; Mo XB
Acta Histochem; 2012 Dec; 114(8):755-62. PubMed ID: 22326401
[TBL] [Abstract][Full Text] [Related]
9. FAM83D knockdown regulates proliferation, migration and invasion of colorectal cancer through inhibiting FBXW7/Notch-1 signalling pathway.
Mu Y; Zou H; Chen B; Fan Y; Luo S
Biomed Pharmacother; 2017 Jun; 90():548-554. PubMed ID: 28407575
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of nemo-like kinase is an independent prognostic factor in colorectal cancer.
Zhang W; He J; Du Y; Gao XH; Liu Y; Liu QZ; Chang WJ; Cao GW; Fu CG
World J Gastroenterol; 2015 Aug; 21(29):8836-47. PubMed ID: 26269673
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of long noncoding RNA ZFAS1 predicts poor prognosis and prompts invasion and metastasis in colorectal cancer.
Wang W; Xing C
Pathol Res Pract; 2016 Aug; 212(8):690-5. PubMed ID: 27461828
[TBL] [Abstract][Full Text] [Related]
12. Regulation of Glioma Cells Migration by DYRK2.
Shen Y; Zhang L; Wang D; Bao Y; Liu C; Xu Z; Huang W; Cheng C
Neurochem Res; 2017 Nov; 42(11):3093-3102. PubMed ID: 28677030
[TBL] [Abstract][Full Text] [Related]
13. Genetic and epigenetic down-regulation of microRNA-212 promotes colorectal tumor metastasis via dysregulation of MnSOD.
Meng X; Wu J; Pan C; Wang H; Ying X; Zhou Y; Yu H; Zuo Y; Pan Z; Liu RY; Huang W
Gastroenterology; 2013 Aug; 145(2):426-36.e1-6. PubMed ID: 23583431
[TBL] [Abstract][Full Text] [Related]
14. Up-regulation of NEK2 by microRNA-128 methylation is associated with poor prognosis in colorectal cancer.
Takahashi Y; Iwaya T; Sawada G; Kurashige J; Matsumura T; Uchi R; Ueo H; Takano Y; Eguchi H; Sudo T; Sugimachi K; Yamamoto H; Doki Y; Mori M; Mimori K
Ann Surg Oncol; 2014 Jan; 21(1):205-12. PubMed ID: 24046120
[TBL] [Abstract][Full Text] [Related]
15. Dual-specificity tyrosine phosphorylation-regulated kinase 2 (DYRK2) as a novel marker in T1 high-grade and T2 bladder cancer patients receiving neoadjuvant chemotherapy.
Nomura S; Suzuki Y; Takahashi R; Terasaki M; Kimata R; Terasaki Y; Hamasaki T; Kimura G; Shimizu A; Kondo Y
BMC Urol; 2015 Jun; 15():53. PubMed ID: 26087959
[TBL] [Abstract][Full Text] [Related]
16. DYRK2 regulates epithelial-mesenchymal-transition and chemosensitivity through Snail degradation in ovarian serous adenocarcinoma.
Yamaguchi N; Mimoto R; Yanaihara N; Imawari Y; Hirooka S; Okamoto A; Yoshida K
Tumour Biol; 2015 Aug; 36(8):5913-23. PubMed ID: 25712377
[TBL] [Abstract][Full Text] [Related]
17. Decreased expression of semaphorin 3D is associated with genesis and development in colorectal cancer.
Wang Z; Ding M; Qian N; Song B; Yu J; Tang J; Wang J
World J Surg Oncol; 2017 Mar; 15(1):67. PubMed ID: 28320475
[TBL] [Abstract][Full Text] [Related]
18. DCLK1 is up-regulated and associated with metastasis and prognosis in colorectal cancer.
Gao T; Wang M; Xu L; Wen T; Liu J; An G
J Cancer Res Clin Oncol; 2016 Oct; 142(10):2131-40. PubMed ID: 27520310
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of SNORA42 as an oncogene and a prognostic biomarker in colorectal cancer.
Okugawa Y; Toiyama Y; Toden S; Mitoma H; Nagasaka T; Tanaka K; Inoue Y; Kusunoki M; Boland CR; Goel A
Gut; 2017 Jan; 66(1):107-117. PubMed ID: 26475630
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of DNAJB6 promotes colorectal cancer cell invasion through an IQGAP1/ERK-dependent signaling pathway.
Zhang TT; Jiang YY; Shang L; Shi ZZ; Liang JW; Wang Z; Zhang Y; Hao JJ; Jia XM; Xu X; Cai Y; Zhan QM; Wang MR
Mol Carcinog; 2015 Oct; 54(10):1205-13. PubMed ID: 25044025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]